Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
Condition(s):Head and Neck NeoplasmsLast Updated:February 26, 2024Active, not recruiting